The launch of the Retatru vial marks a significant breakthrough in the field to weight regulation. This novel drug combines dual mechanisms – stimulation of the GLP-1 site and inhibition of the DPP-4 factor – offering a distinctive strategy for addressing excess weight . Early patient results dem… Read More